It looks like you're using an unsecure version of Internet Explorer. Using an outdated browser makes your computer unsafe. For the best and safest website experience, please update your
or please use
Diabetes & endocrinology | GPnotebook TV
This site is intended for UK healthcare professionals
Dr Kevin Fernando summarises results from the cardiovascular outcomes trial of ertugliflozin presented at the American Diabetes Association’s 2020 congress, along with the implications for primary care.
During this hour-long broadcast, Dr Kevin Fernando, Professor David Wheeler and Dr Amrit Lamba consider the recent license extension to Invokana® (canagliflozin) and how this could change the management of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) in primary care.
In this "Deep Dive" into COVID-19, Dr Kevin Fernando, Dr Yassir Javaid, Su Down and Dr Andrew Frankel discuss the key considerations for managing people with established cardiovascular disease, diabetes or chronic kidney disease during the pandemic.
In Part 4 of a five-part series covering the recent NICE guideline on thyroid disease, Dr David Millar-Jones considers practical points regarding both subclinical hyperthyroidism and subclinical hypothyroidism.
The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.